1. Nonmyeloablative Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia in Patients 60 Years or Older 
Vikas Gupta, Andrew Daly, Jeffrey H. Lipton, Wanda Hasegawa, Kathy Chun, Suzanne Kamel-Reid, Richard Tsang, Qi-long Yi, Mark Minden, Hans Messner, Thomas Kiss 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 10, Pages (October 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of chronic GVHD (the risk of dying from any cause was treated as a competing event).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Kaplan-Meier plots of progression-free and overall survival of older patients with MDS or AML undergoing nonmyeloablative stem cell transplantation. The 2-year progression-free and overall survival rates were 44% (95% CI, 23%-82%) and 52% (95% CI, 34%-81%), respectively.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions